Open access
116
Views
11
CrossRef citations to date
0
Altmetric
Original Research
Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs
Sandra M Axiak1 Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USA
, Kim A Selting1 Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USACorrespondence[email protected]
, Charles J Decedue2 CritiTech Inc, Lawrence, KS, USA
, Carolyn J Henry1 Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USA;3 Department of Internal Medicine, Division of Hematology and Oncology, University of Missouri, Columbia, MO, USA
, Deborah Tate1 Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USA
, Jahna Howell2 CritiTech Inc, Lawrence, KS, USA
, K James Bilof1 Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USA
& Dae Y Kim4 Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA
show all
Pages 2205-2212
|
Published online: 11 Oct 2011
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.